The document discusses several challenges and priorities in liver transplantation. It focuses on hepatitis B and C, liver cancer, and non-alcoholic steatohepatitis as common indications for transplantation. Immunosuppression strategies aim to minimize side effects while preventing rejection. Outcomes have improved with new antiviral therapies, though recurrent disease remains a challenge.